Diagnostic Ventures

🗓 Founded 2022👥 8 employees💰 Last funded Sep 2024
Biotechnology Research🌐 diagnosticventures.net
Website LinkedIn
Diagnostic Ventures is a company focused on creating novel diagnostic medical technologies. Annually, sepsis affects 50 million people worldwide, with over 11 million deaths. Our company has a patented process that uses blood from a patient presenting with sepsis symptoms and produces results within 1 hour which identifies the most dangerous antimicrobial resistant genes present in bacteria that cause bloodstream infections. Our Rapid Sepsis test will help save lives, by quickly identifying patients who have this type of infection and providing doctors the tools to quickly prescribe the right antibiotics for sepsis infections.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Diagnostic Ventures?
Diagnostic Ventures has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Diagnostic Ventures last raise funding?
The most recent investment in Diagnostic Ventures recorded on gritt.io was in September 2024.
When was Diagnostic Ventures founded?
Diagnostic Ventures was founded in 2022.
What industry is Diagnostic Ventures in?
Diagnostic Ventures operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.